VECTURA V Trademark

Trademark Overview


On Thursday, November 3, 2016, a trademark application was filed for VECTURA V with the United States Patent and Trademark Office. The USPTO has given the VECTURA V trademark a serial number of 79204968. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2018. This trademark is owned by Vectura Limited. The VECTURA V trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biological preparations for medical purposes, namely for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prev...

Medical apparatus and instruments, namely drug delivery devices, namely drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods

Scientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing
vectura v

General Information


Serial Number79204968
Word MarkVECTURA V
Filing DateThursday, November 3, 2016
Status700 - REGISTERED
Status DateTuesday, February 13, 2018
Registration Number5398606
Registration DateTuesday, February 13, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 28, 2017

Trademark Statements


Description of MarkThe mark consists of the letter "V" made up of 6 oblique lines and a small triangle appearing next to the stylized word "VECTURA".
Goods and ServicesPharmaceutical and biological preparations for medical purposes, namely for the treatment of diseases or conditions of the respiratory system; pharmaceutical and biological preparations for medical purposes, namely the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynaecological conditions; pharmaceutical and biological preparations for medical purposes, namely for the alleviation or prevention of pain or inflammation; pharmaceutical and biological preparations for medical purposes, namely, powders for asthma inhalers; pharmaceutical and biological preparations for medical purposes, namely, powders for transdermal injection for the alleviation or prevention of pain, for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for oral ingestion for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genitourinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purposes, namely for topical administration for the treatment of diseases or conditions of the respiratory system, diseases or conditions of the cardiovascular system, diabetes, cancer, arthritis, diseases or conditions of the gastro-intestinal system, diseases or conditions of the central nervous system, diseases or conditions of the endocrine system, diseases or conditions of the genito-urinary system, infections, skin disorders and gynecological conditions; pharmaceutical and biological preparations for medical purpose, namely, medicaments for inhalation therapy; pharmaceutical and biological preparations for medical purposes, namely, pulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticals, namely, drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; pharmaceutical and biological preparations for medical purpose, namely medicaments for the treatment of erectile dysfunction, medicaments for the treatment of chronic obstructive pulmonary disease, medicaments for the treatment of premature ejaculation, medicaments for the treatment of cystic fibrosis, medicaments for the treatment of female sexual dysfunction, medicaments for the treatment of migraines, medicaments for the treatment of asthma
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical apparatus and instruments, namely drug delivery devices, namely drug delivery systems; inhalers for medical use; metered dose inhalers for medical use; active dry powder inhalers for medical use; passive dry powder inhalers for medical use; nebulisers for respiration therapy; respirators for artificial respiration; parts and fittings for all the aforesaid goods
Goods and ServicesScientific research, development, design, analysis, testing and investigation relating to medical preparations and drug delivery devices; medical research; research relating to drug delivery devices; research relating to drug formulation; pharmaceutical development; preparation and formulation of pharmaceuticals; device and product testing

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 14, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 14, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 14, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVectura Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGB

Party NameVectura Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGB

Party NameVectura Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGB

Trademark Events


Event DateEvent Description
Friday, December 22, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 13, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, October 8, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, July 13, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, May 23, 2018FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, May 23, 2018FINAL DISPOSITION PROCESSED
Sunday, May 13, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 13, 2018REGISTERED-PRINCIPAL REGISTER
Friday, December 8, 2017NOTIFICATION PROCESSED BY IB
Tuesday, November 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 28, 2017PUBLISHED FOR OPPOSITION
Wednesday, November 22, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 22, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 20, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 11, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 11, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 11, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 13, 2017REFUSAL PROCESSED BY IB
Tuesday, April 25, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, April 24, 2017REFUSAL PROCESSED BY MPU
Thursday, April 20, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, April 19, 2017NON-FINAL ACTION WRITTEN
Tuesday, April 18, 2017APPLICATION FILING RECEIPT MAILED
Friday, April 14, 2017ASSIGNED TO EXAMINER
Friday, April 14, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 13, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB